Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 6/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17138197 | 0.85 | BCHE (0.61) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL17138200 | 0.74 | GAA (0.43) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL17138153 | 0.70 | KDM4E (0.56) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL11641394 | 0.70 | CYP3A4 (0.50) | GAAATMCYP19A1CYP3A4 | |
| SCHEMBL17138137 | 0.69 | BCHE (0.58) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL14286960 | 0.68 | L3MBTL1 (0.53) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL17138221 | 0.68 | ALDH1A1 (0.60) | CYP3A4ABCG2ABCB1 | |
| SCHEMBL26985478 | 0.67 | L3MBTL1 (0.61) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL27314199 | 0.67 | L3MBTL1 (0.65) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL17138145 | 0.67 | ADORA3 (0.51) | GAAXBP1ATMNPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | GAA 4138/4885XBP1 3610/4885ATM 3215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.